Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: Role of cyclic GMP

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 319-327

  Forloni, Gianluigi ^a   Lucca, Elisa ^a   Angeretti, Nadia ^a   Chiesa, Roberto ^a   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cell death; Cyclic GMP; Neuronal calcium; Somatostatin

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; OCTREOTIDE; PERTUSSIS TOXIN; SOMATOSTATIN; VAPREOTIDE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG ANTAGONISM; FETUS; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031027726     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010319.x     Document Type: Article

References (60)

1. Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64, 2087-2096.
2. Behl C., Hovey L., Kraiewski S., Schubert D., and Reed J. C. (1993) BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Commun. 197, 949-956.
3. Brezeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., and Guillemin R. (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 197, 77-79.
4. Butt E., Van Bemmelen M., Fischer L., and Jastoroff B. (1990) Inhibition by cGMP-dependent protein kinase by (Rp)-guanosine 3′-5′ monophosphorothioesters. FEBS Lett. 263, 47-50.
5. Choi D. W., Koh J., and Peters S. (1988) Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8, 185-196.
6. Csernansky C. A., Canzoniero L. M., Sensi S. L., and Choi D. W. (1994) Delayed application of aurintricarboxylic acid reduces glutamate-induced cortical neuronal injury. J. Neurosci. Res. 38, 101-108.
7. Davies P., Katzman R., and Terry R. O. (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's senile dementia. Nature 288, 279-280.
8. Dessi F., Charriaut-Marlangue C., Khrestchatisky M., and Ben-Ari Y. (1993) Glutamate-induced neuronal death is not a programmed cell death in cerebellar culture. J. Neurochem. 60, 1953-1955.
9. Epelbaum J. (1986) Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 27, 63-100.
10. Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. P. Jr., Bird A. D., and Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 561-563.
11. Forloni G., Hohmann C., and Coyle J. (1990) Developmental expression of somatostatin in mouse brain. I. Immunocytochemical studies. Dev. Brain Res. 53, 6-25.
12. Forloni G., Demicheli F., Giorgi S., Bendotti C., and Angeretti N. (1992) Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol. Brain Res. 16, 128-134.
13. Forloni G., Chiesa R., Angeretti N., Monzani E., Salmona M., Bugiani O., and Tagliavini F. (1993a) Neurotoxicity of a prion protein fragment. Nature 362, 543-546.
14. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., and Angeretti N. (1993b) Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. Neuroreport 4, 523-526.
15. Forloni G., Angeretti N., and Smiroldo S. (1994) Neuroprotective activity of acetyl-carnitine: studies in vitro. J. Neurosci. Res. 37, 92-96.
16. + channels and suppression of neuronal activity by secreted β-amyloid-precursor protein. Nature 379, 74-78.
17. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J. Neurosci. 13, 1993-2000.
18. Hidaka H., Inagaki M., Kawamoto S., and Sasaki Y. (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041.
19. Hoyer D., Lübbert H., and Bruns C. (1994) Molecular pharmacology of somatostatin receptors. Naunyn Schmiedebergs Arch. Pharmacol 350, 441-453.
20. Ignatowicz E., Vezzani A., Rizzi M., and D'Incalci M. (1991) Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis. Neuroreport 2, 651-654.
21. Joseph R., Li W., and Han E. (1993) Neuronal death, cytoplasmatic calcium and internucleosomal DNA fragmentation: evidence for DNA fragments being released from cells. Mol. Brain Res. 17, 70-76.
22. Kaupmann K., Bruns C., Hoyer D., Seuwen K., and Lübbert G. (1991) Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett. 331, 53-59.
23. Kihara S., Shiraishi T., Nakagawa S., Toda K., and Tabuchi K. (1994) Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci. Lett. 175, 133-136.
24. Koh J.-Y., Goldberg M. P., Hartley D. M., and Choi D. W. (1990) Non-NMDA receptor-mediated neurotoxicity in cortical culture. J. Neurosci. 10, 693-705.
25. Kong H., De Paoli A. M., Breder C. D., Yasuda K., Bell G. I., and Reisine T. (1994) Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2 and SSTR3 in adult rat brain: analysis by RNA blotting and in situ hybridization histochemistry. Neuroscience 59, 175-184.
26. Kure S., Tominaga T., Yoshimoto T., Tada K., and Narisawa K. (1991) Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun. 179, 39-45.
27. Lewis D. L., Weight F. F., and Luini A. (1986) A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line. Proc. Natl. Acad. Sci. USA 83, 9035-9039.
28. Lusting H. S., von Brauchitsch K. L., Chan J., and Greenberg D. A. (1992) Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures. Brain Res. 577, 343-346.
29. Mahy N., Woolkas M., Thermos K., Carlson K., Manning D., and Reisine T. (1988) Pertussis toxin modifies the characteristics of both the inhibitory GTP-binding protein and the somatostatin receptor in anterior pituitary tumor cells. J. Pharmacol. Exp. Ther. 246, 779-785.
30. Manfridi A., Forloni G., Vezzani A., Fodritto F., and De Simoni M. G. (1991) Functional and histological consequences of quinolinic and kainic acid-induced seizures of hippocampal somatostatin neurons. Neuroscience 41, 127-135.
31. Martin J. L., Chesselet M.-F., Raynor K., Gonzales C., and Reisine T. (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41, 581-593.
32. Mazurek M. F. and Beal F. M. (1991) Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex. Neurology 41, 716-719.
33. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11(Special Report), 54-61.
34. 2+ current modulated by cGMP-dependent protein kinase. Nature 369, 336-339.
35. Mitchell I. J., Lawson S., Moser B., Laidlaw S. M., Cooper A. J., Walkinshaw G., and Waters C. M. (1994) Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat. Neuroscience 63, 1-5.
36. Monno A., Rizzi M., Samanin R., and Vezzani A. (1993) Anti-somatostatin antibody enhances the rate of hippocampal kindling. Brain Res. 602, 148-152.
37. Montpied P., Weller M., and Paul S. M. (1993) N-Methyl-D-aspartate receptor agonists decrease protooncogene BCL-2 mRNA expression in cultured rat cerebellar granule neurons. Biochem. Biophys. Res. Commun. 195, 623-629.
38. Moore S. T., Madamba S. G., Joëls M., and Siggins G. R. (1988) Somatostatin augments the M-current in hippocampal neurons. Science 239, 278-280.
39. 2+ in toxic cell killing. Trends Pharmacol. Sci. 10, 281-285.
40. Patel S. C., Papachristou D. N., and Patel Y. C. (1991) Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons. J. Neurochem. 56, 1286-1291.
41. Patel Y. C. and Srikant C. B. (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135, 2814-2817.
42. Perez J., Rigo M., Kaupmann K., Bruns C., Yasuda K., Bell G. I., Lübbert H., and Hoyer D. (1994) Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn Schmiedebergs Arch. Pharmacol. 349, 1-16.
43. 2+ entry blockers prevent glutamate-induced neurotoxicity. Eur. J. Pharmacol. 209, 169-173.
44. Pollard H., Cantagrel S., Charriaut-Marlangue C., Moreau J., and Ben Ari Y. (1994a) Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 5, 1053-1055.
45. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., and Ben Ari Y. (1994b) Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63, 7-18.
46. Serghini R., Froissard P., Sola B., and Duval D. (1994) Cycloheximide and actinomycin D block the toxic effect of glutamic acid on PC12 cells. Neuroreport 6, 29-32.
47. Sucher N. J., Lei S. Z., and Lipton S. A. (1991) Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 297, 297-302.
48. Tapia-Arancibia L. and Astier H. (1988) Glutamate stimulates somatostatin release from diencephalic neurons in primary culture. Endocrinology 123, 2360-2366.
49. Vécsei L. (1993) Alzheimer's disease and somatostatin: a therapeutic hypothesis. Biol. Psychiatry 34, 673-675.
50. Vezzani A., Serafini R., Stasi M. A., Viganò G., Rizzi M., and Samanin R. (1991) A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic acid and kainic acids differently in the rat hippocampus. Neuropharmacology 30, 342-352.
51. Vezzani A., Monno A., Rizzi M., Galli A., Barrios M., and Samanin R. (1992) Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats. Neuroscience 51, 41-46.
52. Wang H. L., Bogen C., Reisine T., and Dichter M. (1989) Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc. Natl. Acad. Sci. USA 86, 9616-9620.
53. Wang H.-L., Reisine T., and Dichter M. (1990) Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons. Neuroscience 38, 335-342.
54. Watson T. W. J. and Pittman Q. J. (1988) Somatostatin-14 and somatostatin-28 but not somatostatin-28(1-12) hyperpolarize CA1 pyramidal neurons in vitro. Brain Res. 448, 40-45.
55. Weill C. L. (1991) Neuroprotective effect of somatostatin on motoneuron cells. Dev. Neurosci. 13, 377-381.
56. Weill C. L. and Greene D. P. (1984) Prevention of natural motoneurone cell death by dibutyryl cyclic GMP. Nature 308, 452-454.
57. Williams J. S., Berbekar I., and Weiss S. (1991) N-Methyl-D-aspartate evokes the release of somatostatin from striatal interneurons in primary culture. Neuroscience 43, 437-444.
58. Wyllie A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 255-256.
59. Zeevalk G. D., Schoepp D., and Nicklas W. J. (1993) Aurintricarboxylic acid prevents NMDA-mediated excitotoxicity: evidence for its action as an NMDA receptor antagonist. J. Neurochem. 61, 386-389.
60. Zhong L.-T., Kane D. J., and Bredesen D. E. (1993) BCL-2 blocks glutamate toxicity in neuronal cell lines. Mol. Brain Res. 19, 353-355.